GlassScriptPhysician profile
Michael D Siegenthaler
NPI 1639550460
$797.13
in general payments reported to CMS, 2019-2025
12 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.33 · 2023: $249 · 2024: $237 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $142.34 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $133.46 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $100.10 | 2021-2025 | Mounjaro, Zepbound |
| Abiomed | $85.28 | 2024 | Impella |
| Baxter Healthcare | $63.55 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Abbott Laboratories | $56.69 | 2023-2024 | Freestyle Libre 2, Epic |
| Phathom Pharmaceuticals, INC. | $48.28 | 2025 | Voquezna |
| Glaxosmithkline, LLC. | $45.88 | 2023-2025 | Trelegy Ellipta, Arexvy |
| Pfizer INC. | $37.90 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.90 | 2025 | Jardiance |
| Exact Sciences Corporation | $33.64 | 2023 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $15.11 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Siegenthaler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.